207 related articles for article (PubMed ID: 38321014)
1. Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production.
Molina-López C; Hurtado-Navarro L; García CJ; Angosto-Bazarra D; Vallejo F; Tapia-Abellán A; Marques-Soares JR; Vargas C; Bujan-Rivas S; Tomás-Barberán FA; Arostegui JI; Pelegrin P
Nat Commun; 2024 Feb; 15(1):1096. PubMed ID: 38321014
[TBL] [Abstract][Full Text] [Related]
2. MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition.
Vande Walle L; Stowe IB; Šácha P; Lee BL; Demon D; Fossoul A; Van Hauwermeiren F; Saavedra PHV; Šimon P; Šubrt V; Kostka L; Stivala CE; Pham VC; Staben ST; Yamazoe S; Konvalinka J; Kayagaki N; Lamkanfi M
PLoS Biol; 2019 Sep; 17(9):e3000354. PubMed ID: 31525186
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies.
Moltrasio C; Romagnuolo M; Marzano AV
Front Immunol; 2022; 13():1007705. PubMed ID: 36275641
[TBL] [Abstract][Full Text] [Related]
4. Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes
Gritsenko A; Yu S; Martin-Sanchez F; Diaz-Del-Olmo I; Nichols EM; Davis DM; Brough D; Lopez-Castejon G
Front Immunol; 2020; 11():565924. PubMed ID: 33101286
[TBL] [Abstract][Full Text] [Related]
5. Cryo-sensitive aggregation triggers NLRP3 inflammasome assembly in cryopyrin-associated periodic syndrome.
Karasawa T; Komada T; Yamada N; Aizawa E; Mizushina Y; Watanabe S; Baatarjav C; Matsumura T; Takahashi M
Elife; 2022 May; 11():. PubMed ID: 35616535
[TBL] [Abstract][Full Text] [Related]
6.
Nakanishi H; Kawashima Y; Kurima K; Chae JJ; Ross AM; Pinto-Patarroyo G; Patel SK; Muskett JA; Ratay JS; Chattaraj P; Park YH; Grevich S; Brewer CC; Hoa M; Kim HJ; Butman JA; Broderick L; Hoffman HM; Aksentijevich I; Kastner DL; Goldbach-Mansky R; Griffith AJ
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7766-E7775. PubMed ID: 28847925
[TBL] [Abstract][Full Text] [Related]
7. Isoliquiritigenin inhibits NLRP3 inflammasome activation with CAPS mutations by suppressing caspase-1 activation and mutated NLRP3 aggregation.
Usui-Kawanishi F; Kani K; Karasawa T; Honda H; Takayama N; Takahashi M; Takatsu K; Nagai Y
Genes Cells; 2024 May; 29(5):423-431. PubMed ID: 38366709
[TBL] [Abstract][Full Text] [Related]
8. CANE, a Component of the NLRP3 Inflammasome, Promotes Inflammasome Activation.
Kaneko N; Kurata M; Yamamoto T; Sakamoto A; Takada Y; Kosako H; Takeda H; Sawasaki T; Masumoto J
J Immunol; 2024 Jul; 213(1):86-95. PubMed ID: 38787200
[TBL] [Abstract][Full Text] [Related]
9. Nlrp3 inflammasome activation in macrophages suffices for inducing autoinflammation in mice.
Frising UC; Ribo S; Doglio MG; Malissen B; van Loo G; Wullaert A
EMBO Rep; 2022 Jul; 23(7):e54339. PubMed ID: 35574994
[TBL] [Abstract][Full Text] [Related]
10. MCC950 blocks enhanced interleukin-1β production in patients with NLRP3 low penetrance variants.
Schuh E; Groß CJ; Wagner D; Schlüter M; Groß O; Kümpfel T
Clin Immunol; 2019 Jun; 203():45-52. PubMed ID: 30974290
[TBL] [Abstract][Full Text] [Related]
11. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP.
Lee GS; Subramanian N; Kim AI; Aksentijevich I; Goldbach-Mansky R; Sacks DB; Germain RN; Kastner DL; Chae JJ
Nature; 2012 Dec; 492(7427):123-7. PubMed ID: 23143333
[TBL] [Abstract][Full Text] [Related]
12. HSP90β controls NLRP3 autoactivation.
Spel L; Hou C; Theodoropoulou K; Zaffalon L; Wang Z; Bertoni A; Volpi S; Hofer M; Gattorno M; Martinon F
Sci Adv; 2024 Mar; 10(9):eadj6289. PubMed ID: 38416826
[TBL] [Abstract][Full Text] [Related]
13. Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.
Brydges SD; Broderick L; McGeough MD; Pena CA; Mueller JL; Hoffman HM
J Clin Invest; 2013 Nov; 123(11):4695-705. PubMed ID: 24084736
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of NLRP3 inflammasome by designed peptide originating from ASC.
Sušjan P; Lainšček D; Strmšek Ž; Hodnik V; Anderluh G; Hafner-Bratkovič I
FASEB J; 2020 Aug; 34(8):11068-11086. PubMed ID: 32648626
[TBL] [Abstract][Full Text] [Related]
15. The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.
Li JY; Wang YY; Shao T; Fan DD; Lin AF; Xiang LX; Shao JZ
J Biol Chem; 2020 Jan; 295(4):1120-1141. PubMed ID: 31852739
[TBL] [Abstract][Full Text] [Related]
16. Gain of function mutation and inflammasome driven diseases in human and mouse models.
Cordero MD; Alcocer-Gómez E; Ryffel B
J Autoimmun; 2018 Jul; 91():13-22. PubMed ID: 29610014
[TBL] [Abstract][Full Text] [Related]
17. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Coll RC; Robertson AA; Chae JJ; Higgins SC; Muñoz-Planillo R; Inserra MC; Vetter I; Dungan LS; Monks BG; Stutz A; Croker DE; Butler MS; Haneklaus M; Sutton CE; Núñez G; Latz E; Kastner DL; Mills KH; Masters SL; Schroder K; Cooper MA; O'Neill LA
Nat Med; 2015 Mar; 21(3):248-55. PubMed ID: 25686105
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Molecular Phenotypes of Low-Penetrance Variants of NLRP3: Diagnostic and Therapeutic Challenges.
Kuemmerle-Deschner JB; Verma D; Endres T; Broderick L; de Jesus AA; Hofer F; Blank N; Krause K; Rietschel C; Horneff G; Aksentijevich I; Lohse P; Goldbach-Mansky R; Hoffman HM; Benseler SM
Arthritis Rheumatol; 2017 Nov; 69(11):2233-2240. PubMed ID: 28692792
[TBL] [Abstract][Full Text] [Related]
19. Induction of Myeloid-Derived Suppressor Cells in Cryopyrin-Associated Periodic Syndromes.
Ballbach M; Hall T; Brand A; Neri D; Singh A; Schaefer I; Herrmann E; Hansmann S; Handgretinger R; Kuemmerle-Deschner J; Hartl D; Rieber N
J Innate Immun; 2016; 8(5):493-506. PubMed ID: 27351923
[TBL] [Abstract][Full Text] [Related]
20. A functional inflammasome activation assay differentiates patients with pathogenic NLRP3 mutations and symptomatic patients with low penetrance variants.
Rieber N; Gavrilov A; Hofer L; Singh A; Öz H; Endres T; Schäfer I; Handgretinger R; Hartl D; Kuemmerle-Deschner J
Clin Immunol; 2015 Mar; 157(1):56-64. PubMed ID: 25596455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
